Clinical trial

Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test

NCT05629494

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2022-09-27

PhasePHASE4

Study timeline

Study start (actual)2022-09-27Date precision: day

Registry last updated2024-10-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Prostate Inflammationunresolved

PSAunresolved

Interventions

Ibuprofen 400 mg, TIDDRUG

PSA testDIAGNOSTIC_TEST

Sponsors & collaborators

Albany Medical Collegelead sponsor

Mapped research locations

ChicagoIllinois, United States1 AlbanyNew York, United States1 HersheyPennsylvania, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05629494 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.